Eloxx Pharmaceuticals (ELOX) Reports Q2 Loss of $0.42/Share
Eloxx Pharmaceuticals (NASDAQ: ELOX) reported Q2 EPS of ($0.42), versus ($1.04) reported last year.
For earnings history and earnings-related data on Eloxx Pharmaceuticals (ELOX) click here.